Risk of Blood Clots in Hospitalized Patients with Immune Diseases
Author Information
Author(s): Ramagopalan Sreeram V, Wotton Clare J, Handel Adam E, Yeates David, Goldacre Michael J
Primary Institution: Wellcome Trust Centre for Human Genetics, University of Oxford
Hypothesis
Do people admitted to hospital with immune-mediated diseases have an increased risk of venous thromboembolism (VTE)?
Conclusion
People admitted to hospital with immune-mediated diseases may be at an increased risk of subsequent VTE.
Supporting Evidence
- Elevated risks of VTE were found in patients with autoimmune diseases.
- Rate ratios for systemic lupus erythematosus were significantly high across different populations.
- The study used a large dataset to analyze the risk of VTE in immune-mediated diseases.
Takeaway
If you go to the hospital with certain immune diseases, you might be more likely to get blood clots afterwards.
Methodology
The study analyzed linked hospital admission and death certificate records to determine VTE rates in patients with immune-mediated diseases.
Potential Biases
Potential bias due to unmeasured migration and lack of data on treatment and confounding factors.
Limitations
The study is exploratory and based on prevalent cases, lacking clinical and laboratory data.
Participant Demographics
The study included a diverse population from the Oxford NHS region and the whole of England.
Statistical Information
P-Value
<0.001
Confidence Interval
3.61 (2.36 to 5.31) for systemic lupus erythematosus
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website